HuagongsheHuagongshe Chemistry Print Report · For research reference only
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole → N-[6-(1H-pyrazol-4-yl)[1,2,4]triazolo[1,5-a]pyridin-2-yl]benzamide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | HCID 2774010 | — |
| Reactant | N-(6-bromo[1,2,4]triazolo[1,5-a]pyridin-2-yl)benzamide | HCID 25212517 | — |
| Product | N-[6-(1H-pyrazol-4-yl)[1,2,4]triazolo[1,5-a]pyridin-2-yl]benzamide | HCID 59437521 | — |
Reaction Steps
The title compound was prepared following procedure described for example 112 but starting from N-(6-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-yl)-benzamide ((B5), 95 mg, 0.3 mmol, 1 eq.) and 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1h-pyrazole (Boron-Mol, 85 mg, 0.36 mmol, 1.2 mol eq.) as a white solid (6.2 mg, 7%). HPLC, Rt: 2.26 min (purity: 99%). LC/MS M+(ESI): 305.2.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08263595B2 |
| Source dataset | uspto-grants-2012_09 |
| ORD ID | ord-8fb407868b424594bfbeac46c3eedf17 |
| Source note | uspto-grants-2012_09 |